Link to a translation of the article:
Die WE&ME-Stiftung der Familie Ströck hat einen neuen Forschungsaufruf zur Multisystemerkrankung ME/CFS gestartet. Insgesamt werden, neben schon laufenden Projekten, rund zwei Millionen Euro an neuen Fördermitteln bereitgestellt. Koordiniert wird der Forschungscall vom Wiener Wissenschafts-...
www-sn-at.translate.goog
It's a nice article that makes clear the huge contribution one family is making to ME/CFS research funding.
Excerpt:
New ME/CFS funding from private funds from 2027
The WE&ME Foundation of the Ströck family has launched a new call for research on the multisystem disease ME/CFS. In addition to ongoing projects, around two million euros in new funding will be made available in total. The research call is coordinated by the Vienna Science, Research and Technology Fund (WWTF). Several biomedical projects are to be funded, WWTF program manager Benjamin Missbach told the APA.
The funding call is carried out by the WWTF on behalf of the Foundation and is intended for several international projects. In a first round, six to seven smaller projects are financed. These are to run for up to two years from the beginning of 2027, about one million euros will be available for this. For the best of them, further financing with a higher budget totalling about one million euros is planned. In addition, for the next four years, two young researchers or Researchers were awarded an award for special achievements in the field of ME/CFS, each in the amount of around 5,000 euros.
International Expert Jury
The application for the purely privately financed research funding through donations is already possible, the funds are to be granted this year. The selection will be made through an international jury of experts, led by molecular biologist and ME/CFS specialist Mauren Hanson from Cornell University in New York.
Also represented on the board are the post-Covid expert and professor for rehabilitation at the Icahn School of Medicine (Mount Sinai/New York) David Putrino, the geneticist Chris Ponting from the University of Edinburgh and the immunologist Michal Tal from the Massachusetts Institute of Technology (USA).
Ströck: Patient participation decisive
The WE&ME Foundation particularly emphasises that the jury is also staffed with three patient representatives (plus two substitute members). A funding structure is needed, "in which the voices of those affected are not only heard, but institutionally supported," emphasised Christoph Ströck from the WE&ME Foundation, who himself is seriously ill with ME/CFS, in a written statement to the APA. "We have therefore conceived the WE&ME Call from the beginning in such a way that the patient's view is structurally engrained. Our cooperation partner Science for ME - the most important international ME/CFS patient forum - has helped to shape the call from the beginning and is part of the international jury. This is unusual in research funding, but it has to be the same with ME/CFS."
"Patients are critical, detail-oriented and have high expectations," says Ströck. "No one has stronger incentives to choose the best research than those affected themselves. If patients also have expertise in relevant specialist areas, this is a particularly strong basis for excellent funding decisions." Their comments are usually "precise and lead to better research results in the end".
Another WE&ME promotion award before launch
In July, it will also be announced which project will receive the funding prize of 450,000 euros, also financed by the WE&ME Foundation and awarded together with the Austrian Science Fund FWF.
........ more at the link